FLAURA2
Regimen
- Experimental
- osimertinib + platinum+pemetrexed
- Control
- osimertinib
Population
Advanced EGFR-mut NSCLC, chemo-naive
Key finding
mPFS 25.5 vs 16.7 mo, HR 0.62 (0.49-0.79); TKI+chemo 可作为高危选项
Source: PMID 37937763
Timeline
- Enrollment start: 2019-07-02 📎
Guideline citations
- NCCN NSCLC Version 5.2026 (p.201)
- CSCO NSCLC 2025 ⚠️ OCR source